Find uplifting stories about heroes, innovations, and solutions
107 results for "lymphoma"
A breakthrough "off-the-shelf" CAR-T therapy eliminated residual cancer cells three times more effectively than standard care in lymphoma patients. The treatment could prevent cancer recurrence in high-risk patients for the first time.
More than 250 lymphoma survivors will learn stress management and coping techniques through a groundbreaking national trial. The free virtual program treats resilience as a teachable skill, not something you're born with.
A lymphoma survivor in Qatar is sharing his cancer journey to give hope to others facing similar battles. Mohamed Othman's story of faith and determination shows that recovery is possible even through the toughest challenges.
St. David's South Austin became the first hospital globally to enroll a patient in a groundbreaking lymphoma treatment trial. The new therapy targets cancer cells in ways previous treatments couldn't reach, offering hope to patients who've run out of options.
Robert Oman has been cancer-free for two decades thanks to a clinical trial that's rewriting what doctors thought possible about follicular lymphoma. New research shows 42% of patients may be functionally cured of a disease once considered incurable.
A 15-year study reveals that 42% of advanced follicular lymphoma patients can now be considered cured after standard treatment, challenging decades of medical belief that this cancer was incurable. Relapse rates dropped from nearly 7% in the first five years to just 0.6% after 15 years.
The FDA just approved Beqalzi, the first BCL2 inhibitor for patients with relapsed mantle cell lymphoma who've tried other treatments. Over half the patients in trials responded to the new therapy, offering fresh hope for those with limited options.
Dogs with lymphoma finally have treatments designed just for them. Two new FDA-approved drugs are giving veterinarians powerful, proven tools to fight one of the most common cancers in dogs.
A groundbreaking blood cancer trial in Melbourne achieved 96% remission rates by swapping harsh chemo drugs with gentler immunotherapy. Three young Victorians remain cancer-free three years later.
Lonenetta Bradford waited a quarter century to ring the cancer survivor's bell at CARTI, finally getting her moment of closure surrounded by family and friends. Her journey from a shocking diagnosis to writing a book about faith and resilience shows that healing happens on its own timeline.
Doctors are finally cracking the code on rare T-cell lymphomas that have resisted treatment for decades. A team of researchers across eight major U.S. medical centers is mapping personalized treatments that could transform survival rates.
A groundbreaking clinical trial has just given Japanese patients with an aggressive form of lymphoma a powerful new treatment option. The SUNMO trial results convinced Japan's health ministry to approve the therapy as a new standard of care.
Ben Whitehead entered remission from a one-of-a-kind lymphoma after targeted therapy starved his cancer cells. The Mount Gambier father went from three months to live to planning his future in just eight months.
A breakthrough treatment combination for early-stage Hodgkin lymphoma achieved complete remission in 92% of patients while requiring less chemotherapy than traditional approaches. The promising results could transform how doctors treat this blood cancer.
Hannah Everett fought Hodgkin lymphoma twice before high school. Now she's graduating from UK's College of Nursing to help children facing the same fear she once lived through.
The FDA just approved two new treatment combinations for cancer patients who've run out of options. These approvals bring fresh hope to people battling mantle cell lymphoma.
Brady Engel crossed a 5K finish line just 30 days after a stem cell transplant for his second fight with lymphoma. The Miami Dolphins employee turned his team's motto into a personal rally cry.
Beloved Australian comedian Magda Szubanski announced she's in remission after completing chemotherapy for stage four mantle cell lymphoma. The Kath and Kim star shared the "fantastic news" nine months after her rare blood cancer diagnosis.
Welsh footballer David Brooks missed the 2022 World Cup while recovering from Stage Two Hodgkin lymphoma and grueling chemotherapy. Four years later, he's not just back on the pitch—he's playing the best football of his career.
Professional footballer David Brooks was diagnosed with Stage Two Hodgkin lymphoma at age 24, watching from the stands as his Wales teammates played in the 2022 World Cup. Now he's not just back on the pitch—he's playing better than ever before.
Showing 20 of 107